- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT00006248
S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Evaluation of Three Hour Infusion of Paclitaxel Plus Cisplatin and 5-Fluorouracil in Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN)
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have metastatic or recurrent head and neck cancer.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
OBJECTIVES:
- Determine the overall survival of patients with metastatic or recurrent squamous cell carcinoma of the head and neck treated with paclitaxel, cisplatin, and fluorouracil.
- Determine response (unconfirmed, confirmed, complete, and partial) and time to treatment failure in patients with measurable disease treated with this regimen.
- Determine the toxic effects of this regimen in these patients.
OUTLINE: Patients receive paclitaxel IV over 3 hours followed by cisplatin IV over 30 minutes on day 1 and fluorouracil IV over 24 hours on days 1-4. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients achieving complete response (CR) receive 3 additional courses beyond CR.
Patients are followed every 3 months for 1 year and then every 6 months for 2 years.
PROJECTED ACCRUAL: A total of 65 patients will be accrued for this study within 12 months.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Fase 2
Contatti e Sedi
Luoghi di studio
-
-
Alabama
-
Mobile, Alabama, Stati Uniti, 36688
- MBCCOP - Gulf Coast
-
-
Arizona
-
Phoenix, Arizona, Stati Uniti, 85006-2726
- CCOP - Greater Phoenix
-
Phoenix, Arizona, Stati Uniti, 85012
- Veterans Affairs Medical Center - Phoenix (Carl T. Hayden)
-
Tucson, Arizona, Stati Uniti, 85724
- Arizona Cancer Center
-
Tucson, Arizona, Stati Uniti, 85723
- Veterans Affairs Medical Center - Tucson
-
-
Arkansas
-
Little Rock, Arkansas, Stati Uniti, 72205
- University of Arkansas for Medical Sciences
-
Little Rock, Arkansas, Stati Uniti, 72205
- Veterans Affairs Medical Center - Little Rock (McClellan)
-
-
California
-
Duarte, California, Stati Uniti, 91010
- City of Hope Comprehensive Cancer Center
-
Los Angeles, California, Stati Uniti, 90095-1781
- Jonsson Comprehensive Cancer Center, UCLA
-
Los Angeles, California, Stati Uniti, 90033-0804
- USC/Norris Comprehensive Cancer Center and Hospital
-
Martinez, California, Stati Uniti, 94553
- Veterans Affairs Outpatient Clinic - Martinez
-
Oakland, California, Stati Uniti, 94609-3305
- CCOP - Bay Area Tumor Institute
-
Orange, California, Stati Uniti, 92868
- Chao Family Comprehensive Cancer Center
-
Sacramento, California, Stati Uniti, 95817
- University of California Davis Cancer Center
-
Santa Rosa, California, Stati Uniti, 95403
- CCOP - Santa Rosa Memorial Hospital
-
Travis Air Force Base, California, Stati Uniti, 94535
- David Grant Medical Center
-
-
Colorado
-
Denver, Colorado, Stati Uniti, 80220
- Veterans Affairs Medical Center - Denver
-
Denver, Colorado, Stati Uniti, 80010
- University of Colorado Cancer Center
-
-
District of Columbia
-
Washington, District of Columbia, Stati Uniti, 20060
- MBCCOP - Howard University Cancer Center
-
-
Georgia
-
Atlanta, Georgia, Stati Uniti, 30342-1701
- CCOP - Atlanta Regional
-
Fort Gordon, Georgia, Stati Uniti, 30905-5650
- Dwight David Eisenhower Army Medical Center
-
-
Hawaii
-
Honolulu, Hawaii, Stati Uniti, 96859-5000
- Tripler Army Medical Center
-
Honolulu, Hawaii, Stati Uniti, 96813-2424
- Cancer Research Center of Hawaii
-
-
Illinois
-
Chicago, Illinois, Stati Uniti, 60612-7323
- MBCCOP - University of Illinois at Chicago
-
Chicago, Illinois, Stati Uniti, 60612
- Veterans Affairs Medical Center - Chicago (Westside Hospital)
-
Decatur, Illinois, Stati Uniti, 62526
- CCOP - Central Illinois
-
Hines, Illinois, Stati Uniti, 60141
- Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital)
-
Maywood, Illinois, Stati Uniti, 60153-5500
- Loyola University Medical Center
-
-
Iowa
-
Davenport, Iowa, Stati Uniti, 52804
- Genesis Medical Center
-
-
Kansas
-
Kansas City, Kansas, Stati Uniti, 66160-7353
- University of Kansas Medical Center
-
Wichita, Kansas, Stati Uniti, 67214-3882
- CCOP - Wichita
-
Wichita, Kansas, Stati Uniti, 67218
- Veterans Affairs Medical Center - Wichita
-
-
Kentucky
-
Lexington, Kentucky, Stati Uniti, 40536-0084
- Albert B. Chandler Medical Center, University of Kentucky
-
Lexington, Kentucky, Stati Uniti, 40502-2236
- Veterans Affairs Medical Center - Lexington
-
-
Louisiana
-
New Orleans, Louisiana, Stati Uniti, 70112
- Tulane University School of Medicine
-
New Orleans, Louisiana, Stati Uniti, 70112
- MBCCOP - LSU Medical Center
-
Shreveport, Louisiana, Stati Uniti, 71130-3932
- Louisiana State University Health Sciences Center - Shreveport
-
Shreveport, Louisiana, Stati Uniti, 71130
- Veterans Affairs Medical Center - Shreveport
-
-
Massachusetts
-
Boston, Massachusetts, Stati Uniti, 02118
- Boston Medical Center
-
Jamaica Plain, Massachusetts, Stati Uniti, 02130
- Veterans Affairs Medical Center - Boston (Jamaica Plain)
-
-
Michigan
-
Ann Arbor, Michigan, Stati Uniti, 48105
- Veterans Affairs Medical Center - Ann Arbor
-
Ann Arbor, Michigan, Stati Uniti, 48106
- CCOP - Ann Arbor Regional
-
Ann Arbor, Michigan, Stati Uniti, 48109-0912
- University of Michigan Comprehensive Cancer Center
-
Detroit, Michigan, Stati Uniti, 48202
- Henry Ford Hospital
-
Detroit, Michigan, Stati Uniti, 48201-1379
- Barbara Ann Karmanos Cancer Institute
-
Detroit, Michigan, Stati Uniti, 48201-1932
- Veterans Affairs Medical Center - Detroit
-
Grand Rapids, Michigan, Stati Uniti, 49503
- CCOP - Grand Rapids
-
Royal Oak, Michigan, Stati Uniti, 48073-6769
- CCOP - Beaumont
-
Southfield, Michigan, Stati Uniti, 48075-9975
- Providence Hospital - Southfield
-
-
Mississippi
-
Biloxi, Mississippi, Stati Uniti, 39531-2410
- Veterans Affairs Medical Center - Biloxi
-
Jackson, Mississippi, Stati Uniti, 39216-4505
- University of Mississippi Medical Center
-
Jackson, Mississippi, Stati Uniti, 39216
- Veterans Affairs Medical Center - Jackson
-
Keesler AFB, Mississippi, Stati Uniti, 39534-2576
- Keesler Medical Center - Keesler AFB
-
-
Missouri
-
Kansas City, Missouri, Stati Uniti, 64128
- Veterans Affairs Medical Center - Kansas City
-
Kansas City, Missouri, Stati Uniti, 64131
- CCOP - Kansas City
-
Saint Louis, Missouri, Stati Uniti, 63141
- CCOP - St. Louis-Cape Girardeau
-
Saint Louis, Missouri, Stati Uniti, 63110
- St. Louis University Health Sciences Center
-
Springfield, Missouri, Stati Uniti, 65807
- CCOP - Cancer Research for the Ozarks
-
-
Montana
-
Billings, Montana, Stati Uniti, 59101
- CCOP - Montana Cancer Consortium
-
-
New Mexico
-
Albuquerque, New Mexico, Stati Uniti, 87108-5138
- Veterans Affairs Medical Center - Albuquerque
-
Albuquerque, New Mexico, Stati Uniti, 87131
- MBCCOP - University of New Mexico HSC
-
-
New York
-
Albany, New York, Stati Uniti, 12208
- Veterans Affairs Medical Center - Albany
-
New York, New York, Stati Uniti, 10032
- Herbert Irving Comprehensive Cancer Center
-
Rochester, New York, Stati Uniti, 14642
- University of Rochester Medical Center
-
-
North Carolina
-
Winston-Salem, North Carolina, Stati Uniti, 27104-4241
- CCOP - Southeast Cancer Control Consortium
-
-
Ohio
-
Cincinnati, Ohio, Stati Uniti, 45220-2288
- Veterans Affairs Medical Center - Cincinnati
-
Cincinnati, Ohio, Stati Uniti, 45267-0501
- Barrett Cancer Center
-
Cleveland, Ohio, Stati Uniti, 44195-9001
- Cleveland Clinic Taussig Cancer Center
-
Columbus, Ohio, Stati Uniti, 43210-1240
- Arthur G. James Cancer Hospital - Ohio State University
-
Columbus, Ohio, Stati Uniti, 43206
- CCOP - Columbus
-
Dayton, Ohio, Stati Uniti, 45428
- Veterans Affairs Medical Center - Dayton
-
Dayton, Ohio, Stati Uniti, 45429
- CCOP - Dayton
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Stati Uniti, 73104
- University of Oklahoma Health Sciences Center
-
Oklahoma City, Oklahoma, Stati Uniti, 73104
- Veterans Affairs Medical Center - Oklahoma City
-
-
Oregon
-
Portland, Oregon, Stati Uniti, 97207
- Veterans Affairs Medical Center - Portland
-
Portland, Oregon, Stati Uniti, 97225
- CCOP - Columbia River Program
-
Portland, Oregon, Stati Uniti, 97239
- Oregon Cancer Institute
-
-
South Carolina
-
Charleston, South Carolina, Stati Uniti, 29425-0721
- Medical University of South Carolina
-
Charleston, South Carolina, Stati Uniti, 29401-5799
- Veterans Affairs Medical Center - Charleston
-
Greenville, South Carolina, Stati Uniti, 29615
- CCOP - Greenville
-
Spartanburg, South Carolina, Stati Uniti, 29303
- CCOP - Upstate Carolina
-
-
Texas
-
Fort Sam Houston, Texas, Stati Uniti, 78234-6200
- Brooke Army Medical Center
-
Galveston, Texas, Stati Uniti, 77555-0565
- University of Texas Medical Branch
-
Houston, Texas, Stati Uniti, 77030
- Veterans Affairs Medical Center - Houston
-
San Antonio, Texas, Stati Uniti, 78284
- Veterans Affairs Medical Center - San Antonio (Murphy)
-
San Antonio, Texas, Stati Uniti, 78284-7845
- University of Texas Health Science Center at San Antonio
-
Temple, Texas, Stati Uniti, 76504
- Veterans Affairs Medical Center - Temple
-
Temple, Texas, Stati Uniti, 76508
- CCOP - Scott and White Hospital
-
-
Utah
-
Salt Lake City, Utah, Stati Uniti, 84148
- Veterans Affairs Medical Center - Salt Lake City
-
Salt Lake City, Utah, Stati Uniti, 84112-5550
- Huntsman Cancer Institute
-
-
Virginia
-
Norfolk, Virginia, Stati Uniti, 23510-1115
- Eastern Virginia Medical School
-
-
Washington
-
Seattle, Washington, Stati Uniti, 98101
- CCOP - Virginia Mason Research Center
-
Seattle, Washington, Stati Uniti, 98108
- Veterans Affairs Medical Center - Seattle
-
Tacoma, Washington, Stati Uniti, 98431-5000
- Madigan Army Medical Center
-
Tacoma, Washington, Stati Uniti, 98405-0986
- CCOP - Northwest
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
DISEASE CHARACTERISTICS:
Histologically confirmed squamous cell carcinoma of the head and neck
- Metastatic at diagnosis or persistent, metastatic, or recurrent after surgery and/or radiotherapy
- Relapse after prior induction or adjuvant therapy allowed
- No newly diagnosed nonmetastatic disease
- Measurable or nonmeasurable disease
PATIENT CHARACTERISTICS:
Age:
- 18 and over
Performance status:
- Zubrod 0-1
Life expectancy:
- Not specified
Hematopoietic:
- Not specified
Hepatic:
- Not specified
Renal:
- Creatinine no greater than 1.5 mg/dL OR
- Creatinine clearance at least 50 mL/min
Other:
- Not pregnant or nursing
- Fertile patients must use effective contraception
- No grade 2 or greater sensory neuropathy
- No other prior malignancy within the past 5 years except adequately treated basal cell or squamous cell skin cancer, carcinoma in situ of the cervix, or stage I or II cancer in complete remission
PRIOR CONCURRENT THERAPY:
Biologic therapy:
- No concurrent biologic therapy
Chemotherapy:
- See Disease Characteristics
- At least 6 months since prior carboplatin or cisplatin induction or adjuvant chemotherapy
- No more than 1 prior induction or adjuvant chemotherapy regimen
- No prior chemotherapy for recurrent or newly diagnosed metastatic disease
- No other concurrent chemotherapy
Endocrine therapy:
- No concurrent anticancer hormonal therapy
Radiotherapy:
- See Disease Characteristics
- At least 28 days since prior radiotherapy and recovered
- No concurrent radiotherapy
Surgery:
- See Disease Characteristics
- At least 28 days since prior surgery and recovered
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Overall Survival
Lasso di tempo: Every 3 weeks while on protocol treatment, then every 3 months for the first year, and then every 6 years thereafter for up to 3 years.
|
Overall survival was defined as the duration from the date of registration until the date of death due to any cause.
Patients last known to be alive were censored at the date of last contact.
|
Every 3 weeks while on protocol treatment, then every 3 months for the first year, and then every 6 years thereafter for up to 3 years.
|
Collaboratori e investigatori
Sponsor
Collaboratori
Investigatori
- Cattedra di studio: Maha Hadi A. Hussain, MD, University of Michigan Rogel Cancer Center
Pubblicazioni e link utili
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
- carcinoma a cellule squamose in stadio IV del labbro e del cavo orale
- carcinoma a cellule squamose ricorrenti del labbro e del cavo orale
- carcinoma a cellule squamose stadio IV dell'orofaringe
- carcinoma a cellule squamose ricorrente dell'orofaringe
- Carcinoma a cellule squamose del rinofaringe in stadio IV
- carcinoma a cellule squamose ricorrenti del rinofaringe
- Carcinoma a cellule squamose stadio IV dell'ipofaringe
- carcinoma a cellule squamose ricorrenti dell'ipofaringe
- Carcinoma a cellule squamose della laringe in stadio IV
- carcinoma a cellule squamose ricorrenti della laringe
- carcinoma a cellule squamose stadio IV del seno paranasale e della cavità nasale
- carcinoma a cellule squamose ricorrente del seno paranasale e della cavità nasale
Termini MeSH pertinenti aggiuntivi
- Neoplasie
- Neoplasie per sede
- Neoplasie della testa e del collo
- Effetti fisiologici delle droghe
- Meccanismi molecolari dell'azione farmacologica
- Antimetaboliti, Antineoplastici
- Antimetaboliti
- Agenti antineoplastici
- Agenti immunosoppressivi
- Fattori immunologici
- Modulatori della tubulina
- Agenti antimitotici
- Modulatori della mitosi
- Agenti antineoplastici, fitogenici
- Paclitaxel
- Cisplatino
- Fluorouracile
Altri numeri di identificazione dello studio
- CDR0000068180
- U10CA032102 (Sovvenzione/contratto NIH degli Stati Uniti)
- S0007 (Altro identificatore: SWOG)
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Cancro testa e collo
-
Novartis PharmaceuticalsReclutamentoEGFR mutante avanzato Non SmallSellLung Cancer (NSCLC), KRAS G12-mutant NSCLC, Esophageal SquamousCell Cancer (SCC), Head/Neck SCC, MelanomaOlanda, Corea, Repubblica di, Spagna, Taiwan, Giappone, Italia, Canada, Stati Uniti, Singapore
Prove cliniche su fluorouracile
-
SanofiCompletatoNeoplasie della testa e del colloCina
-
University Hospital of CreteCompletatoCancro colorettale metastaticoGrecia
-
Encube Ethicals Pvt. Ltd.CBCC Global ResearchCompletato
-
M.D. Anderson Cancer CenterReclutamentoMetastasi epaticheStati Uniti